A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1559-0275

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s disease ; volume:17 ; number:1 ; day:5 ; month:6 ; year:2020 ; pages:1-24 ; date:12.2020
Clinical proteomics ; 17, Heft 1 (5.6.2020), 1-24, 12.2020

Creator: Pedrero-Prieto, Cristina M.
García-Carpintero, Sonia
Frontiñán-Rubio, Javier
Llanos-González, Emilio
Aguilera García, Cristina
Alcaín, Francisco J.
Lindberg, Iris
Durán-Prado, Mario
Peinado, Juan R.
Rabanal-Ruiz, Yoana

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12014-020-09276-9

URN: urn:nbn:de:101:1-2020080622220407303382

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pedrero-Prieto, Cristina M.
García-Carpintero, Sonia
Frontiñán-Rubio, Javier
Llanos-González, Emilio
Aguilera García, Cristina
Alcaín, Francisco J.
Lindberg, Iris
Durán-Prado, Mario
Peinado, Juan R.
Rabanal-Ruiz, Yoana
SpringerLink (Online service)

Other Objects (12)

The plasma peptides of Alzheimer’s disease

Inflammation context in Alzheimer’s disease, a relationship intricate to define

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

The plasma peptides of Alzheimer’s disease

Inflammation context in Alzheimer’s disease, a relationship intricate to define

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

The plasma peptides of Alzheimer’s disease

Inflammation context in Alzheimer’s disease, a relationship intricate to define

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The plasma peptides of Alzheimer’s disease

Inflammation context in Alzheimer’s disease, a relationship intricate to define

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

The plasma peptides of Alzheimer’s disease

Inflammation context in Alzheimer’s disease, a relationship intricate to define

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

The plasma peptides of Alzheimer’s disease

Inflammation context in Alzheimer’s disease, a relationship intricate to define

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Disease staging of Alzheimer’s disease using a CSF-based biomarker model

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

Related objects

Reset password